Breaking News Instant updates and real-time market news.

MMI

Marcus & Millichap

$39.48 /

-0.06 (-0.15%)

12:55
02/24/21
02/24
12:55
02/24/21
12:55

Marcus & Millichap to host virtual investor meeting

Virtual Investor Meeting to be held on February 24 at 1 pm. Webcast Link

  • 24

    Feb

  • 24

    Feb

MMI Marcus & Millichap
$39.48 /

-0.06 (-0.15%)

04/09/20 Wells Fargo
Marcus & Millichap downgraded at Wells Fargo on declining transaction volume
04/09/20 Wells Fargo
Marcus & Millichap downgraded to Underweight from Equal Weight at Wells Fargo

TODAY'S FREE FLY STORIES

Recommendations
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler » 11:02
04/12/21
04/12
11:02
04/12/21
11:02
ITOS

iTeos Therapeutics

$25.41 /

-1.495 (-5.56%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITOS iTeos Therapeutics
$25.41 /

-1.495 (-5.56%)

ITOS iTeos Therapeutics
$25.41 /

-1.495 (-5.56%)

04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
ITOS iTeos Therapeutics
$25.41 /

-1.495 (-5.56%)

  • 24
    Jul
Recommendations
Provention Bio price target lowered to $22.50 from $35 at Chardan » 11:02
04/12/21
04/12
11:02
04/12/21
11:02
PRVB

Provention Bio

$8.00 /

+0.01 (+0.13%)

Chardan analyst Gbola…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRVB Provention Bio
$8.00 /

+0.01 (+0.13%)

PRVB Provention Bio
$8.00 /

+0.01 (+0.13%)

04/09/21 SVB Leerink
Provention Bio price target lowered to $16 from $26 at SVB Leerink
04/09/21 RBC Capital
Provention Bio cut to Sector Perform at RBC Capital after teplizumab FDA notice
04/09/21 Cantor Fitzgerald
Provention Bio price target lowered to $25 from $27 at Cantor Fitzgerald
04/09/21 RBC Capital
Provention Bio downgraded to Sector Perform from Outperform at RBC Capital
PRVB Provention Bio
$8.00 /

+0.01 (+0.13%)

  • 14
    Jan
  • 18
    Jun
PRVB Provention Bio
$8.00 /

+0.01 (+0.13%)

Recommendations
Sage Therapeutics essential tremor data 'a win,' says Piper Sandler » 10:58
04/12/21
04/12
10:58
04/12/21
10:58
SAGE

Sage Therapeutics

$74.43 /

-2.3 (-3.00%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$74.43 /

-2.3 (-3.00%)

SAGE Sage Therapeutics
$74.43 /

-2.3 (-3.00%)

04/07/21 Piper Sandler
Sage Therapeutics assumed with an Overweight at Piper Sandler
02/26/21 Mizuho
Sage Therapeutics downgraded to Neutral from Buy at Mizuho
02/25/21 Oppenheimer
Sage Therapeutics price target raised to $102 from $90 at Oppenheimer
02/25/21 H.C. Wainwright
Sage Therapeutics price target raised to $86 from $74 at H.C. Wainwright
SAGE Sage Therapeutics
$74.43 /

-2.3 (-3.00%)

SAGE Sage Therapeutics
$74.43 /

-2.3 (-3.00%)

Options
Nautilus put volume heavy and directionally bearish » 10:55
04/12/21
04/12
10:55
04/12/21
10:55
NLS

Nautilus

$16.12 /

-0.455 (-2.75%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NLS Nautilus
$16.12 /

-0.455 (-2.75%)

NLS Nautilus
$16.12 /

-0.455 (-2.75%)

03/19/21 Craig-Hallum
Nautilus price target lowered to $25 from $30 at Craig-Hallum
03/19/21 Roth Capital
Nautilus price target lowered to $26 from $29 at Roth Capital
03/19/21 William Blair
Nautilus 2026 margin target sent shares down 10%, says William Blair
03/19/21 Craig-Hallum
Nautilus price target lowered to $25 from $30 at Craig-Hallum
NLS Nautilus
$16.12 /

-0.455 (-2.75%)

NLS Nautilus
$16.12 /

-0.455 (-2.75%)

NLS Nautilus
$16.12 /

-0.455 (-2.75%)

NLS Nautilus
$16.12 /

-0.455 (-2.75%)

Conference/Events
Microsoft to host conference call » 10:55
04/12/21
04/12
10:55
04/12/21
10:55
NUAN

Nuance

$53.30 /

+7.705 (+16.90%)

, MSFT

Microsoft

$255.41 /

-0.32 (-0.13%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NUAN Nuance
$53.30 /

+7.705 (+16.90%)

MSFT Microsoft
$255.41 /

-0.32 (-0.13%)

NUAN Nuance
$53.30 /

+7.705 (+16.90%)

08:30 Today Stifel
Microsoft a 'logical buyer' of Nuance, says Stifel
07:36 Today B. Riley
Nuance possible takeout positive for peer LivePerson, says B. Riley
07:29 Today Wedbush
Nuance deal would be 'trophy' for Microsoft, says Wedbush
03/10/21 Wedbush
Nuance added to Best Ideas List at Wedbush
MSFT Microsoft
$255.41 /

-0.32 (-0.13%)

08:30 Today Stifel
Microsoft a 'logical buyer' of Nuance, says Stifel
07:36 Today B. Riley
Nuance possible takeout positive for peer LivePerson, says B. Riley
07:29 Today Wedbush
Nuance deal would be 'trophy' for Microsoft, says Wedbush
07:11 Today BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
NUAN Nuance
$53.30 /

+7.705 (+16.90%)

MSFT Microsoft
$255.41 /

-0.32 (-0.13%)

NUAN Nuance
$53.30 /

+7.705 (+16.90%)

MSFT Microsoft
$255.41 /

-0.32 (-0.13%)

NUAN Nuance
$53.30 /

+7.705 (+16.90%)

MSFT Microsoft
$255.41 /

-0.32 (-0.13%)

NUAN Nuance
$53.30 /

+7.705 (+16.90%)

MSFT Microsoft
$255.41 /

-0.32 (-0.13%)

Syndicate
Recursion Pharmaceuticals 18M share IPO price range $16.00-$18.00 » 10:49
04/12/21
04/12
10:49
04/12/21
10:49
RXRX

Recursion Pharmaceuticals

/

+

Goldman Sachs and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
SBA sees at least $22.5M more straight-line revenue in 2021 than prior guidance » 10:47
04/12/21
04/12
10:47
04/12/21
10:47
SBAC

SBA Communications

$277.53 /

+2.03 (+0.74%)

, VZ

Verizon

$57.60 /

+0.14 (+0.24%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBAC SBA Communications
$277.53 /

+2.03 (+0.74%)

VZ Verizon
$57.60 /

+0.14 (+0.24%)

SBAC SBA Communications
$277.53 /

+2.03 (+0.74%)

08:01 Today Jefferies
SBA Communications initiated with a Buy at Jefferies
03/25/21 KeyBanc
SBA Communications upgraded to Overweight from Sector Weight at KeyBanc
03/18/21 Wolfe Research
SBA Communications initiated with an Outperform at Wolfe Research
03/05/21 Raymond James
SBA Communications upgraded to Strong Buy from Outperform at Raymond James
VZ Verizon
$57.60 /

+0.14 (+0.24%)

03/30/21 KeyBanc
KeyBanc sees partnership with Google as neutral to T-Mobile
03/24/21 Tigress Financial
Verizon upgraded to Buy at Tigress Financial
03/24/21 Tigress Financial
Verizon upgraded to Buy from Neutral at Tigress Financial
03/12/21 Morgan Stanley
T-Mobile highlighted 'impressive' cash flow ramp at event, says Morgan Stanley
SBAC SBA Communications
$277.53 /

+2.03 (+0.74%)

VZ Verizon
$57.60 /

+0.14 (+0.24%)

SBAC SBA Communications
$277.53 /

+2.03 (+0.74%)

VZ Verizon
$57.60 /

+0.14 (+0.24%)

VZ Verizon
$57.60 /

+0.14 (+0.24%)

VZ Verizon
$57.60 /

+0.14 (+0.24%)

Syndicate
Biomea Fusion 7.5M share IPO price range $15.00-$17.00 » 10:46
04/12/21
04/12
10:46
04/12/21
10:46
BMEA

Biomea Fusion

/

+

JPMorgan, Jefferies and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
180 Life Sciences call volume above normal and directionally bullish » 10:45
04/12/21
04/12
10:45
04/12/21
10:45
ATNF

180 Life Sciences

$12.19 /

+2.49 (+25.67%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATNF 180 Life Sciences
$12.19 /

+2.49 (+25.67%)

ATNF 180 Life Sciences
$12.19 /

+2.49 (+25.67%)

ATNF 180 Life Sciences
$12.19 /

+2.49 (+25.67%)

Syndicate
Akoya Biosciences 6.58M share IPO price range $18.00-$20.00 » 10:44
04/12/21
04/12
10:44
04/12/21
10:44
AKYA

Akoya Biosciences

/

+

JPMorgan, Morgan Stanley,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
PLBY Group shares jump as Hedgeye adds as a new best idea » 10:40
04/12/21
04/12
10:40
04/12/21
10:40
PLBY

PLBY Group

$28.75 /

+2.97 (+11.52%)

PLBY Group (PLBY) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLBY PLBY Group
$28.75 /

+2.97 (+11.52%)

PLBY PLBY Group
$28.75 /

+2.97 (+11.52%)

04/07/21 Roth Capital
PLBY Group price target raised to $35 from $26 at Roth Capital
04/06/21 Canaccord
Canaccord sees Nifty Gateway partnership as initial step in PLBY's NFT strategy
03/31/21 Canaccord
PLBY Group initiated with a Buy at Canaccord
03/24/21 Craig-Hallum
PLBY Group price target raised to $35 from $25 at Craig-Hallum
PLBY PLBY Group
$28.75 /

+2.97 (+11.52%)

PLBY PLBY Group
$28.75 /

+2.97 (+11.52%)

Periodicals
Denmark's DSB orders e-trains from Alstom in $3.2B deal, Reuters reports » 10:39
04/12/21
04/12
10:39
04/12/21
10:39
ALSMY

Alstom

$5.29 /

+0.06 (+1.15%)

DSB, the state-owned…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALSMY Alstom
$5.29 /

+0.06 (+1.15%)

ALSMY Alstom
$5.29 /

+0.06 (+1.15%)

03/17/21 JPMorgan
Alstom price target lowered to EUR 51 from EUR 52 at JPMorgan
03/15/21 Citi
Citi opens 'negative catalyst watch' on Alstom
03/03/21 Morgan Stanley
Alstom price target raised to EUR 59 from EUR 55 at Morgan Stanley
02/23/21 UBS
Alstom price target lowered to EUR 50 from EUR 54 at UBS
Conference/Events
Limbach Holding participates in a conference call hosted by Lake Street » 10:35
04/12/21
04/12
10:35
04/12/21
10:35
LMB

Limbach Holding

$10.88 /

-0.42 (-3.72%)

Lake Street holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMB Limbach Holding
$10.88 /

-0.42 (-3.72%)

LMB Limbach Holding
$10.88 /

-0.42 (-3.72%)

03/05/21
Fly Intel: Top five analyst initiations
03/05/21 Lake Street
Limbach Holding initiated with a Buy at Lake Street
LMB Limbach Holding
$10.88 /

-0.42 (-3.72%)

  • 11
    Feb
Options
KE Holdings put volume heavy and directionally bearish » 10:35
04/12/21
04/12
10:35
04/12/21
10:35
BEKE

KE Holdings

$54.01 /

-1.84 (-3.29%)

Bearish flow noted in KE…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BEKE KE Holdings
$54.01 /

-1.84 (-3.29%)

BEKE KE Holdings
$54.01 /

-1.84 (-3.29%)

04/07/21 Credit Suisse
KE Holdings initiated with an Outperform at Credit Suisse
03/18/21 BofA
KE Holdings upgraded to Buy from Neutral at BofA
03/18/21 BofA
KE Holdings upgraded to Buy from Neutral at BofA
03/11/21 Goldman Sachs
KE Holdings upgraded to Buy from Neutral at Goldman Sachs
BEKE KE Holdings
$54.01 /

-1.84 (-3.29%)

  • 19
    Nov
  • 13
    Aug
BEKE KE Holdings
$54.01 /

-1.84 (-3.29%)

Conference/Events
Boxlight participates in a conference call hosted by Maxim » 10:32
04/12/21
04/12
10:32
04/12/21
10:32
BOXL

Boxlight

$2.36 /

-0.11 (-4.45%)

Maxim hosts conference…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOXL Boxlight
$2.36 /

-0.11 (-4.45%)

BOXL Boxlight
$2.36 /

-0.11 (-4.45%)

03/26/21 Alliance Global Partners
Boxlight price target raised to $5.50 from $5 at Alliance Global Partners
01/26/21 Alliance Global Partners
Boxlight price target raised to $5 from $4 at Alliance Global Partners
10/05/20 Maxim
Boxlight price target raised to $6 from $4 at Maxim
10/01/20 Alliance Global Partners
Boxlight price target raised to $4 from $2.75 at Alliance Global Partners
BOXL Boxlight
$2.36 /

-0.11 (-4.45%)

  • 29
    Jul
  • 09
    Jun
BOXL Boxlight
$2.36 /

-0.11 (-4.45%)

Conference/Events
Sellas Life Sciences participates in a conference call hosted by Maxim » 10:31
04/12/21
04/12
10:31
04/12/21
10:31
SLS

Sellas Life Sciences

$8.45 /

-0.59 (-6.53%)

Maxim hosts conference…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLS Sellas Life Sciences
$8.45 /

-0.59 (-6.53%)

SLS Sellas Life Sciences
$8.45 /

-0.59 (-6.53%)

02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
12/21/20 Alliance Global Partners
Alliance Global Partners keeps Buy on Sellas following data from trials
SLS Sellas Life Sciences
$8.45 /

-0.59 (-6.53%)

SLS Sellas Life Sciences
$8.45 /

-0.59 (-6.53%)

SLS Sellas Life Sciences
$8.45 /

-0.59 (-6.53%)

Options
Micron call volume above normal and directionally bullish » 10:25
04/12/21
04/12
10:25
04/12/21
10:25
MU

Micron

$95.93 /

+0.58 (+0.61%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MU Micron
$95.93 /

+0.58 (+0.61%)

MU Micron
$95.93 /

+0.58 (+0.61%)

04/01/21 Wedbush
Micron price target raised to $105 from $100 at Wedbush
04/01/21 JPMorgan
Micron price target raised to $140 from $130 at JPMorgan
04/01/21 Needham
Micron price target raised to $130 from $115 at Needham
04/01/21 Cowen
Micron price target raised to $105 from $100 at Cowen
MU Micron
$95.93 /

+0.58 (+0.61%)

MU Micron
$95.93 /

+0.58 (+0.61%)

MU Micron
$95.93 /

+0.58 (+0.61%)

MU Micron
$95.93 /

+0.58 (+0.61%)

Conference/Events
Rackspace Technology to hold a virtual roundtable » 10:25
04/12/21
04/12
10:25
04/12/21
10:25
FORR

Forrester

$41.61 /

-0.2 (-0.48%)

, DELL

Dell Technologies

$93.09 /

-0.79 (-0.84%)

, RXT

Rackspace Technology

$25.65 /

-0.42 (-1.61%)

Virtual Roundtable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DELL Dell Technologies
$93.09 /

-0.79 (-0.84%)

RXT Rackspace Technology
$25.65 /

-0.42 (-1.61%)

FORR Forrester
$41.61 /

-0.2 (-0.48%)

02/16/21 Barrington
Forrester price target raised to $50 from $44 at Barrington
08/03/20 Barrington
Forrester price target raised to $44 from $40 at Barrington
DELL Dell Technologies
$93.09 /

-0.79 (-0.84%)

04/08/21 Morgan Stanley
Dell Technologies price target raised to $107 from $98 at Morgan Stanley
04/07/21 Deutsche Bank
Dell Technologies price target raised to $100 from $94 at Deutsche Bank
02/26/21 JPMorgan
Dell Technologies price target raised to $98 from $90 at JPMorgan
02/26/21 Credit Suisse
Dell Technologies price target raised to $80 from $70 at Credit Suisse
RXT Rackspace Technology
$25.65 /

-0.42 (-1.61%)

04/01/21 William Blair
William Blair starts Rackspace with Outperform, sees 30% upside
03/31/21 William Blair
Rackspace Technology initiated with an Outperform at William Blair
01/25/21 Oppenheimer
Rackspace Technology initiated with an Outperform at Oppenheimer
09/01/20 BMO Capital
Rackspace Technology price target raised to $25 from $23 at BMO Capital
FORR Forrester
$41.61 /

-0.2 (-0.48%)

DELL Dell Technologies
$93.09 /

-0.79 (-0.84%)

RXT Rackspace Technology
$25.65 /

-0.42 (-1.61%)

  • 05
    Aug
DELL Dell Technologies
$93.09 /

-0.79 (-0.84%)

RXT Rackspace Technology
$25.65 /

-0.42 (-1.61%)

DELL Dell Technologies
$93.09 /

-0.79 (-0.84%)

RXT Rackspace Technology
$25.65 /

-0.42 (-1.61%)

DELL Dell Technologies
$93.09 /

-0.79 (-0.84%)

RXT Rackspace Technology
$25.65 /

-0.42 (-1.61%)

Conference/Events
Cardiff Oncology to hold a Key Opinion Leader conference call » 10:25
04/12/21
04/12
10:25
04/12/21
10:25
CRDF

Cardiff Oncology

$9.43 /

+0.18 (+1.95%)

CEO Erlander, along with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRDF Cardiff Oncology
$9.43 /

+0.18 (+1.95%)

CRDF Cardiff Oncology
$9.43 /

+0.18 (+1.95%)

02/11/21 Piper Sandler
Piper says Cardiff Oncology mCRPC opportunity 'more interesting' after data
10/22/20
Fly Intel: Top five analyst initiations
10/22/20 H.C. Wainwright
Cardiff Oncology initiated with a Buy at H.C. Wainwright
10/21/20 Maxim
Cardiff Oncology price target raised to $20 from $14 at Maxim
CRDF Cardiff Oncology
$9.43 /

+0.18 (+1.95%)

  • 30
    Sep
CRDF Cardiff Oncology
$9.43 /

+0.18 (+1.95%)

Conference/Events
UBS electric equip/multi-industry analysts hold analyst/industry conference call » 10:25
04/12/21
04/12
10:25
04/12/21
10:25

Electrical Equipment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Nam Tai says ISS, Glass Lewis both say change in board control not warranted » 10:23
04/12/21
04/12
10:23
04/12/21
10:23
NTP

Nam Tai Property

$11.90 /

+0.22 (+1.88%)

Nam Tai Property issued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTP Nam Tai Property
$11.90 /

+0.22 (+1.88%)

On The Fly
Alibaba jumps as China fine seen removing overhang » 10:20
04/12/21
04/12
10:20
04/12/21
10:20
BABA

Alibaba

$242.26 /

+18.91 (+8.47%)

Shares of Alibaba Group…

ShowHide Related Items >><<
BABA Alibaba
$242.26 /

+18.91 (+8.47%)

BABA Alibaba
$242.26 /

+18.91 (+8.47%)

08:37 Today Morgan Stanley
Alibaba named a Research Tactical Idea at Morgan Stanley
07:37 Today Raymond James
Alibaba price target lowered to $330 from $350 at Raymond James
06:41 Today Mizuho
Alibaba antitrust ruling 'removes overhang,' says Mizuho
06:37 Today Citi
Alibaba fine could help lift 'overhang' on shares, says Citi
BABA Alibaba
$242.26 /

+18.91 (+8.47%)

BABA Alibaba
$242.26 /

+18.91 (+8.47%)

BABA Alibaba
$242.26 /

+18.91 (+8.47%)

BABA Alibaba
$242.26 /

+18.91 (+8.47%)

Hot Stocks
Akari announces initiation of pivotal Phase 3 trial of nomacopan in BP » 10:18
04/12/21
04/12
10:18
04/12/21
10:18
AKTX

Akari Therapeutics

$2.41 /

+ (+0.00%)

Akari Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.41 /

+ (+0.00%)

AKTX Akari Therapeutics
$2.41 /

+ (+0.00%)

Recommendations
JinkoSolar businss model 'simply not sustainable,' says GLJ Research » 10:17
04/12/21
04/12
10:17
04/12/21
10:17
JKS

JinkoSolar

$35.56 /

-3.1 (-8.02%)

GLJ Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JKS JinkoSolar
$35.56 /

-3.1 (-8.02%)

JKS JinkoSolar
$35.56 /

-3.1 (-8.02%)

09:54 Today
Fly Intel: Top five analyst downgrades
06:33 Today Roth Capital
JinkoSolar downgraded to Neutral from Buy at Roth Capital
05:34 Today Roth Capital
JinkoSolar downgraded to Neutral from Buy at Roth Capital
02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital
JKS JinkoSolar
$35.56 /

-3.1 (-8.02%)

JKS JinkoSolar
$35.56 /

-3.1 (-8.02%)

JKS JinkoSolar
$35.56 /

-3.1 (-8.02%)

JKS JinkoSolar
$35.56 /

-3.1 (-8.02%)

Technical Analysis
NASDAQ market internals summary » 10:17
04/12/21
04/12
10:17
04/12/21
10:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.